Showing 1 - 2 results of 2 for search 'Laura Arenare', query time: 0.01s Refine Results
  1. 1
    Comparison of baseline patient characteristics in phase 1 and phase 2/3 clinical trials for anticancer treatments

    Comparison of baseline patient characteristics in phase 1 and phase 2/3 clinical trials for anticancer treatments by Maria Lucia Iacovino, Simone Talucci, Laura Arenare, Andrea Caglio, Andrea Canciello, Flavio Salerno, Sergio Facchini, Adriano Gravina, Clorinda Schettino, Maria Carmela Piccirillo, Pier Paolo Olimpieri, Massimo Di Maio, Francesco Perrone

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Programmed death‐ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV‐2 translational study

    Programmed death‐ligand 1 expression and prognostic significance in bevacizumab treated ovarian cancer patients: Results from the phase IV MITO16A/MaNGO OV‐2 translational study... by Francesca Basso‐Valentina, Vincenzo Canzonieri, Rossella De Cecio, Laura Arenare, Domenica Lorusso, Sabrina Chiara Cecere, Eliana Pivetta, Daniela Russo, Annabella Di Mauro, Grazia Artioli, Anna Spina, Carmine De Angelis, Daniela Califano, Saverio Cinieri, Giosuè Scognamiglio, Vanda Salutari, Paolo Chiodini, Francesco Perrone, Sandro Pignata, Gustavo Baldassarre

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: